Literature DB >> 16766101

Percutaneous needle fasciotomy in dupuytren's disease.

A L van Rijssen1, P M N Werker.   

Abstract

The aim of this study was to examine our results of 74 percutaneous needle fasciotomies for Dupuytren's contracture. Pre-operative and postoperative total passive extension deficit was measured. Patients were seen at the outpatient clinic at 32 months for final follow-up. Extension deficit and sensibility were measured and flexor tendon function assessed. Recurrence, defined as an increase of the passive extension deficit of 30 degrees or more compared to the immediate postoperative measurement, and other complications were also noted. Immediate outcome was excellent with an average improvement of 77%. After 32 months, we reviewed 55 rays. Their recurrence rate was 65%. Two patients experienced a slightly diminished sensibility on one side of the finger. There were no flexor tendon injuries. This procedure has a good short-term effect. It may be suitable for patients who want a minimally invasive treatment and to whom long-term results are less important. It may also have a place in delaying fasciectomy.

Entities:  

Mesh:

Year:  2006        PMID: 16766101     DOI: 10.1016/j.jhsb.2006.03.174

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  35 in total

Review 1.  Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Authors:  Marc D Lipman; Samuel Evan Carstensen; Dylan Nicole Deal
Journal:  Hand (N Y)       Date:  2016-05-03

2.  Safety and Effectiveness of Percutaneous Needle Fasciotomy for Dupuytren's Disease in the Palm.

Authors:  Muhammad Mansha; Darren Flynn; John Stothard
Journal:  J Hand Microsurg       Date:  2017-08-08

3.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

Review 4.  [Percutaneous needle aponeurotomy for Dupuytren's contracture].

Authors:  J Oppermann; F Unglaub; L P Müller; S Löw; P Hahn; C K Spies
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 5.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

6.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

7.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

8.  Percutaneous fasciotomy for the treatment of Dupuytren's disease-a systematic review.

Authors:  Saoussen Salhi; Etienne Cardin-Langlois; Mario Luc
Journal:  Hand (N Y)       Date:  2011-08-19

9.  Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.

Authors:  Heather A McMahon; Abdo Bachoura; Sidney M Jacoby; David S Zelouf; Randall W Culp; A Lee Osterman
Journal:  Hand (N Y)       Date:  2013-09

10.  Modified percutaneous needle aponeurotomy for the treatment of dupuytren's contracture: early results and complications.

Authors:  Fernando A Herrera; Scott Mitchell; Mark Elzik; Jason Roostaeian; Prosper Benhaim
Journal:  Hand (N Y)       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.